https://www.onhealthcare.tech/p/the-peptide-split-how-glp-1s-lutathera-f57Thoughts on Healthcare Markets & Technologyen2026-05-08T13:01:24+00:00The Peptide Split: How GLP-1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC-157, TB-500, MOTS-c, and the Wellness Grift Borrow Their Halohttps://www.onhealthcare.tech/p/the-peptide-split-how-glp-1s-lutatheraThoughts on Healthcare Markets & Technologyen2026-05-08T12:41:32+00:00The Peptide Split: How GLP-1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC-157, TB-500, MOTS-c, and the Wellness Grift Borrow Their Halohttps://www.onhealthcare.tech/p/reading-openais-keeping-patients-205Thoughts on Healthcare Markets & Technologyen2026-05-07T16:58:58+00:00Reading OpenAI’s Keeping Patients First Blueprint: What the April 2026 Healthcare Policy Document Proposes on Data Portability, Information Blocking, Regulatory Sandboxes, and FDA Modernization